Discrimination of prostate cancer from benign disease by plasma measurement of intact, free prostate-specific antigen lacking an internal cleavage site at Lys145-Lys146

Clinical Chemistry

Volumn 47, Issue 8, 2001, Pages 1415-1423

  Nurmikko, P ^a   Pettersson, K ^a   Piironen, T ^a   Hugosson, J ^a   Lilja, H ^a  

^a UNIVERSITY OF TURKU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

LYSINE; MONOCLONAL ANTIBODY; PROSTATE SPECIFIC ANTIGEN; TUMOR MARKER;

ADULT; AGED; ANTIBODY LABELING; ARTICLE; BIOTINYLATION; CANCER SCREENING; CONTROLLED STUDY; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; PROSTATE CANCER; PROSTATE DISEASE; PROSTATE HYPERTROPHY; PROTEIN DEGRADATION; PROTEIN PURIFICATION;

EID: 0034921328     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/47.8.1415     Document Type: Article

References (29)

1. Prostate antigen: A new potential marker for prostatic cancer
2. A kallikrein-like serine protease in prostatic fluid cleaves the predominant seminal vesicle protein
3. Seminal vesicle-secreted proteins and their reactions during gelation and liquefaction of human semen
4. α-Macroglobulins. Structure, shape, and mechanism of proteinase complex formation
5. 1-protease inhibitor in serum
6. A complex between prostate-specific antigen and α1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: Assay of the complex improves clinical sensitivity for cancer
7. Serum prostate specific antigen complexed to α1-antichymotrypsin as an indicator of prostate cancer
8. Expression of pro form of prostate-specific antigen by mammalian cells and its conversion to mature, active form by human kallikrein 2
9. Activation of the zymogen form of prostate-specific antigen by human glandular kallikrein 2
10. Enzymatic activity of prostate-specific antigen and its reactions with extracellular serine proteinase inhibitors
11. Human prostate-specific antigen: Structural and functional similarity with serine proteases
12. Purification and characterization of different molecular forms of prostate-specific antigen in human seminal fluid
13. "B-PSA", a specific molecular form of free prostate-specific antigen, is found predominantly in the transition zone of patients with nodular benign prostatic hyperplasia
14. Seminal plasma contains "BPSA", a molecular form of prostate-specific antigen that is associated with benign prostatic hyperplasia
15. LNCaP produces both putative zymogen and inactive, free form of prostate-specific antigen
16. Characterization and processing of prostate specific antigen (hK3) and human glandular kallikrein (hK2) secreted by LNCAP cells
17. A precursor form of PSA (pPSA) is a component of the free PSA in prostate cancer serum
18. Isolation and characterization of free form prostate specific antigen (f-PSA) in sera of men with prostate cancer
19. 1-antichymotrypsin complex in serum but not in prostatic fluid
20. 146 inactive PSA
21. Prostate-specific antigen in serum occurs predominantly in complex with alpha 1-antichymotrypsin
22. 1-antichymotrypsin complex
23. Clinical value of human glandular kallikrein 2 and free and total prostate-specific antigen in serum from a population of men with prostate-specific antigen levels 3.0 ng/ml or greater
24. Software for illustrative presentation of basic clinical characteristics of laboratory tests - GraphROC for Windows
25. Androgen-sensitive human prostate cancer cells, LNCaP, produce both N-terminally mature and truncated prostate-specific antigen isoforms
26. Molecular cloning and expression of an alternative hKLK3 transcript coding for a variant protein of prostate-specific antigen
27. Two-dimensional electrophoresis of prostate-specific antigen in sera of men with prostate cancer or benign prostate hyperplasia
28. The effect of prostate volume, age, total prostate specific antigen level and acute inflammation on the percentage of free serum prostate specific antigen levels in men without clinically detectable prostate cancer
29. In vitro stability of free prostate-specific antigen (PSA) and prostate-specific antigen (PSA) complexed to α1-antichymotrypsin in blood samples